Carbamazepine (CBZ) is a widely used antiepileptic drug that suffers from poor aqueous solubility, which limits its oral bioavailability. Pharmaceutical cocrystallization has gained as an effective strategy to improve the physicochemical properties of poorly soluble drugs without altering their therapeutic activity. In the present study, a cocrystal of carbamazepine with succinic acid (SA) was synthesized using the slurry crystallization method. The prepared cocrystal was analyzed using powder X-ray diffraction (PXRD) to confirm the formation of a new crystalline phase.